Global AI In Vitro Diagnostic Market Research Report 2023

AI In Vitro Diagnostic Market

According to QYResearch’s new survey, global AI In Vitro Diagnostic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI In Vitro Diagnostic market research.

The global market for in vitro diagnostics (IVD) was growing steadily and was expected to continue its growth in the coming years.

Market Overview: The in vitro diagnostics market involves medical devices, instruments, and reagents used for diagnostic testing of samples such as blood, urine, tissue, and other bodily fluids. AI in vitro diagnostics refers to the integration of artificial intelligence and machine learning technologies into these diagnostic tools and processes.

Growth Drivers: The market for AI in vitro diagnostics has been driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic and infectious diseases, technological advancements in diagnostics, and the need for efficient and accurate diagnostic solutions.

Application Areas: AI has found applications in various areas of in vitro diagnostics, including clinical chemistry, immunoassays, microbiology, hematology, genetic testing, and molecular diagnostics. AI algorithms can aid in data analysis, interpretation, and decision-making, improving the accuracy and efficiency of diagnostic procedures.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI In Vitro Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of AI In Vitro Diagnostic Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI In Vitro Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Next-Generation Sequencing Technology

1.2.3 PCR Technology

1.2.4 Chemistry and IA Technology

1.2.5 Pathology Technology

1.3 Market by Application

1.3.1 Global AI In Vitro Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Cancer Diagnostics

1.3.3 Infectious Disease Testing

1.3.4 Metabolic Testing

1.3.5 Cardiac Testing

1.3.6 Diabetes Testing

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global AI In Vitro Diagnostic Market Perspective (2018-2029)

2.2 AI In Vitro Diagnostic Growth Trends by Region

2.2.1 Global AI In Vitro Diagnostic Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 AI In Vitro Diagnostic Historic Market Size by Region (2018-2023)

2.2.3 AI In Vitro Diagnostic Forecasted Market Size by Region (2024-2029)

2.3 AI In Vitro Diagnostic Market Dynamics

2.3.1 AI In Vitro Diagnostic Industry Trends

2.3.2 AI In Vitro Diagnostic Market Drivers

2.3.3 AI In Vitro Diagnostic Market Challenges

2.3.4 AI In Vitro Diagnostic Market Restraints

3.1 Global Top AI In Vitro Diagnostic Players by Revenue

3.1.1 Global Top AI In Vitro Diagnostic Players by Revenue (2018-2023)

3.1.2 Global AI In Vitro Diagnostic Revenue Market Share by Players (2018-2023)

3.2 Global AI In Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by AI In Vitro Diagnostic Revenue

3.4 Global AI In Vitro Diagnostic Market Concentration Ratio

3.4.1 Global AI In Vitro Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI In Vitro Diagnostic Revenue in 2022

3.5 AI In Vitro Diagnostic Key Players Head office and Area Served

3.6 Key Players AI In Vitro Diagnostic Product Solution and Service

3.7 Date of Enter into AI In Vitro Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global AI In Vitro Diagnostic Historic Market Size by Type (2018-2023)

4.2 Global AI In Vitro Diagnostic Forecasted Market Size by Type (2024-2029)

5.1 Global AI In Vitro Diagnostic Historic Market Size by Application (2018-2023)

5.2 Global AI In Vitro Diagnostic Forecasted Market Size by Application (2024-2029)

6.1 North America AI In Vitro Diagnostic Market Size (2018-2029)

6.2 North America AI In Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America AI In Vitro Diagnostic Market Size by Country (2018-2023)

6.4 North America AI In Vitro Diagnostic Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe AI In Vitro Diagnostic Market Size (2018-2029)

7.2 Europe AI In Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe AI In Vitro Diagnostic Market Size by Country (2018-2023)

7.4 Europe AI In Vitro Diagnostic Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific AI In Vitro Diagnostic Market Size (2018-2029)

8.2 Asia-Pacific AI In Vitro Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2018-2023)

8.4 Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America AI In Vitro Diagnostic Market Size (2018-2029)

9.2 Latin America AI In Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America AI In Vitro Diagnostic Market Size by Country (2018-2023)

9.4 Latin America AI In Vitro Diagnostic Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa AI In Vitro Diagnostic Market Size (2018-2029)

10.2 Middle East & Africa AI In Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2018-2023)

10.4 Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Renalytix

11.1.1 Renalytix Company Detail

11.1.2 Renalytix Business Overview

11.1.3 Renalytix AI In Vitro Diagnostic Introduction

11.1.4 Renalytix Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.1.5 Renalytix Recent Development

11.2 Seegene

11.2.1 Seegene Company Detail

11.2.2 Seegene Business Overview

11.2.3 Seegene AI In Vitro Diagnostic Introduction

11.2.4 Seegene Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.2.5 Seegene Recent Development

11.3 Sysmex

11.3.1 Sysmex Company Detail

11.3.2 Sysmex Business Overview

11.3.3 Sysmex AI In Vitro Diagnostic Introduction

11.3.4 Sysmex Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.3.5 Sysmex Recent Development

11.4 PathAI

11.4.1 PathAI Company Detail

11.4.2 PathAI Business Overview

11.4.3 PathAI AI In Vitro Diagnostic Introduction

11.4.4 PathAI Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.4.5 PathAI Recent Development

11.5 Prognos

11.5.1 Prognos Company Detail

11.5.2 Prognos Business Overview

11.5.3 Prognos AI In Vitro Diagnostic Introduction

11.5.4 Prognos Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.5.5 Prognos Recent Development

11.6 Qiagen

11.6.1 Qiagen Company Detail

11.6.2 Qiagen Business Overview

11.6.3 Qiagen AI In Vitro Diagnostic Introduction

11.6.4 Qiagen Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.6.5 Qiagen Recent Development

11.7 CloudMedX Health

11.7.1 CloudMedX Health Company Detail

11.7.2 CloudMedX Health Business Overview

11.7.3 CloudMedX Health AI In Vitro Diagnostic Introduction

11.7.4 CloudMedX Health Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.7.5 CloudMedX Health Recent Development

11.8 Deepcell

11.8.1 Deepcell Company Detail

11.8.2 Deepcell Business Overview

11.8.3 Deepcell AI In Vitro Diagnostic Introduction

11.8.4 Deepcell Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.8.5 Deepcell Recent Development

11.9 Digital Diagnostics

11.9.1 Digital Diagnostics Company Detail

11.9.2 Digital Diagnostics Business Overview

11.9.3 Digital Diagnostics AI In Vitro Diagnostic Introduction

11.9.4 Digital Diagnostics Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.9.5 Digital Diagnostics Recent Development

11.10 EKF Diagnostics Holdings

11.10.1 EKF Diagnostics Holdings Company Detail

11.10.2 EKF Diagnostics Holdings Business Overview

11.10.3 EKF Diagnostics Holdings AI In Vitro Diagnostic Introduction

11.10.4 EKF Diagnostics Holdings Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.10.5 EKF Diagnostics Holdings Recent Development

11.11 Freenome

11.11.1 Freenome Company Detail

11.11.2 Freenome Business Overview

11.11.3 Freenome AI In Vitro Diagnostic Introduction

11.11.4 Freenome Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.11.5 Freenome Recent Development

11.12 GE Healthcare

11.12.1 GE Healthcare Company Detail

11.12.2 GE Healthcare Business Overview

11.12.3 GE Healthcare AI In Vitro Diagnostic Introduction

11.12.4 GE Healthcare Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.12.5 GE Healthcare Recent Development

11.13 Glooko

11.13.1 Glooko Company Detail

11.13.2 Glooko Business Overview

11.13.3 Glooko AI In Vitro Diagnostic Introduction

11.13.4 Glooko Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.13.5 Glooko Recent Development

11.14 Adaptive Biotechnologies

11.14.1 Adaptive Biotechnologies Company Detail

11.14.2 Adaptive Biotechnologies Business Overview

11.14.3 Adaptive Biotechnologies AI In Vitro Diagnostic Introduction

11.14.4 Adaptive Biotechnologies Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.14.5 Adaptive Biotechnologies Recent Development

11.15 Aidoc

11.15.1 Aidoc Company Detail

11.15.2 Aidoc Business Overview

11.15.3 Aidoc AI In Vitro Diagnostic Introduction

11.15.4 Aidoc Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.15.5 Aidoc Recent Development

11.16 Anumana

11.16.1 Anumana Company Detail

11.16.2 Anumana Business Overview

11.16.3 Anumana AI In Vitro Diagnostic Introduction

11.16.4 Anumana Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.16.5 Anumana Recent Development

11.17 ARUP Laboratories

11.17.1 ARUP Laboratories Company Detail

11.17.2 ARUP Laboratories Business Overview

11.17.3 ARUP Laboratories AI In Vitro Diagnostic Introduction

11.17.4 ARUP Laboratories Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.17.5 ARUP Laboratories Recent Development

11.18 K Health

11.18.1 K Health Company Detail

11.18.2 K Health Business Overview

11.18.3 K Health AI In Vitro Diagnostic Introduction

11.18.4 K Health Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.18.5 K Health Recent Development

11.19 Lunit

11.19.1 Lunit Company Detail

11.19.2 Lunit Business Overview

11.19.3 Lunit AI In Vitro Diagnostic Introduction

11.19.4 Lunit Revenue in AI In Vitro Diagnostic Business (2018-2023)

11.19.5 Lunit Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global AI In Vitro Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Next-Generation Sequencing Technology

    Table 3. Key Players of PCR Technology

    Table 4. Key Players of Chemistry and IA Technology

    Table 5. Key Players of Pathology Technology

    Table 6. Global AI In Vitro Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global AI In Vitro Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global AI In Vitro Diagnostic Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global AI In Vitro Diagnostic Market Share by Region (2018-2023)

    Table 10. Global AI In Vitro Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global AI In Vitro Diagnostic Market Share by Region (2024-2029)

    Table 12. AI In Vitro Diagnostic Market Trends

    Table 13. AI In Vitro Diagnostic Market Drivers

    Table 14. AI In Vitro Diagnostic Market Challenges

    Table 15. AI In Vitro Diagnostic Market Restraints

    Table 16. Global AI In Vitro Diagnostic Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global AI In Vitro Diagnostic Market Share by Players (2018-2023)

    Table 18. Global Top AI In Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Vitro Diagnostic as of 2022)

    Table 19. Ranking of Global Top AI In Vitro Diagnostic Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by AI In Vitro Diagnostic Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players AI In Vitro Diagnostic Product Solution and Service

    Table 23. Date of Enter into AI In Vitro Diagnostic Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global AI In Vitro Diagnostic Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global AI In Vitro Diagnostic Revenue Market Share by Type (2018-2023)

    Table 27. Global AI In Vitro Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global AI In Vitro Diagnostic Revenue Market Share by Type (2024-2029)

    Table 29. Global AI In Vitro Diagnostic Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global AI In Vitro Diagnostic Revenue Market Share by Application (2018-2023)

    Table 31. Global AI In Vitro Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global AI In Vitro Diagnostic Revenue Market Share by Application (2024-2029)

    Table 33. North America AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America AI In Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America AI In Vitro Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe AI In Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe AI In Vitro Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific AI In Vitro Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America AI In Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America AI In Vitro Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Renalytix Company Detail

    Table 49. Renalytix Business Overview

    Table 50. Renalytix AI In Vitro Diagnostic Product

    Table 51. Renalytix Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 52. Renalytix Recent Development

    Table 53. Seegene Company Detail

    Table 54. Seegene Business Overview

    Table 55. Seegene AI In Vitro Diagnostic Product

    Table 56. Seegene Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 57. Seegene Recent Development

    Table 58. Sysmex Company Detail

    Table 59. Sysmex Business Overview

    Table 60. Sysmex AI In Vitro Diagnostic Product

    Table 61. Sysmex Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 62. Sysmex Recent Development

    Table 63. PathAI Company Detail

    Table 64. PathAI Business Overview

    Table 65. PathAI AI In Vitro Diagnostic Product

    Table 66. PathAI Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 67. PathAI Recent Development

    Table 68. Prognos Company Detail

    Table 69. Prognos Business Overview

    Table 70. Prognos AI In Vitro Diagnostic Product

    Table 71. Prognos Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 72. Prognos Recent Development

    Table 73. Qiagen Company Detail

    Table 74. Qiagen Business Overview

    Table 75. Qiagen AI In Vitro Diagnostic Product

    Table 76. Qiagen Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 77. Qiagen Recent Development

    Table 78. CloudMedX Health Company Detail

    Table 79. CloudMedX Health Business Overview

    Table 80. CloudMedX Health AI In Vitro Diagnostic Product

    Table 81. CloudMedX Health Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 82. CloudMedX Health Recent Development

    Table 83. Deepcell Company Detail

    Table 84. Deepcell Business Overview

    Table 85. Deepcell AI In Vitro Diagnostic Product

    Table 86. Deepcell Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 87. Deepcell Recent Development

    Table 88. Digital Diagnostics Company Detail

    Table 89. Digital Diagnostics Business Overview

    Table 90. Digital Diagnostics AI In Vitro Diagnostic Product

    Table 91. Digital Diagnostics Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 92. Digital Diagnostics Recent Development

    Table 93. EKF Diagnostics Holdings Company Detail

    Table 94. EKF Diagnostics Holdings Business Overview

    Table 95. EKF Diagnostics Holdings AI In Vitro Diagnostic Product

    Table 96. EKF Diagnostics Holdings Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 97. EKF Diagnostics Holdings Recent Development

    Table 98. Freenome Company Detail

    Table 99. Freenome Business Overview

    Table 100. Freenome AI In Vitro Diagnostic Product

    Table 101. Freenome Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 102. Freenome Recent Development

    Table 103. GE Healthcare Company Detail

    Table 104. GE Healthcare Business Overview

    Table 105. GE Healthcare AI In Vitro Diagnostic Product

    Table 106. GE Healthcare Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 107. GE Healthcare Recent Development

    Table 108. Glooko Company Detail

    Table 109. Glooko Business Overview

    Table 110. Glooko AI In Vitro Diagnostic Product

    Table 111. Glooko Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 112. Glooko Recent Development

    Table 113. Adaptive Biotechnologies Company Detail

    Table 114. Adaptive Biotechnologies Business Overview

    Table 115. Adaptive Biotechnologies AI In Vitro Diagnostic Product

    Table 116. Adaptive Biotechnologies Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 117. Adaptive Biotechnologies Recent Development

    Table 118. Aidoc Company Detail

    Table 119. Aidoc Business Overview

    Table 120. Aidoc AI In Vitro Diagnostic Product

    Table 121. Aidoc Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 122. Aidoc Recent Development

    Table 123. Anumana Company Detail

    Table 124. Anumana Business Overview

    Table 125. Anumana AI In Vitro Diagnostic Product

    Table 126. Anumana Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 127. Anumana Recent Development

    Table 128. ARUP Laboratories Company Detail

    Table 129. ARUP Laboratories Business Overview

    Table 130. ARUP Laboratories AI In Vitro Diagnostic Product

    Table 131. ARUP Laboratories Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 132. ARUP Laboratories Recent Development

    Table 133. K Health Company Detail

    Table 134. K Health Business Overview

    Table 135. K Health AI In Vitro Diagnostic Product

    Table 136. K Health Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 137. K Health Recent Development

    Table 138. Lunit Company Detail

    Table 139. Lunit Business Overview

    Table 140. Lunit AI In Vitro Diagnostic Product

    Table 141. Lunit Revenue in AI In Vitro Diagnostic Business (2018-2023) & (US$ Million)

    Table 142. Lunit Recent Development

    Table 143. Research Programs/Design for This Report

    Table 144. Key Data Information from Secondary Sources

    Table 145. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global AI In Vitro Diagnostic Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global AI In Vitro Diagnostic Market Share by Type: 2022 VS 2029

    Figure 3. Next-Generation Sequencing Technology Features

    Figure 4. PCR Technology Features

    Figure 5. Chemistry and IA Technology Features

    Figure 6. Pathology Technology Features

    Figure 7. Global AI In Vitro Diagnostic Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global AI In Vitro Diagnostic Market Share by Application: 2022 VS 2029

    Figure 9. Cancer Diagnostics Case Studies

    Figure 10. Infectious Disease Testing Case Studies

    Figure 11. Metabolic Testing Case Studies

    Figure 12. Cardiac Testing Case Studies

    Figure 13. Diabetes Testing Case Studies

    Figure 14. AI In Vitro Diagnostic Report Years Considered

    Figure 15. Global AI In Vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global AI In Vitro Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global AI In Vitro Diagnostic Market Share by Region: 2022 VS 2029

    Figure 18. Global AI In Vitro Diagnostic Market Share by Players in 2022

    Figure 19. Global Top AI In Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Vitro Diagnostic as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by AI In Vitro Diagnostic Revenue in 2022

    Figure 21. North America AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America AI In Vitro Diagnostic Market Share by Country (2018-2029)

    Figure 23. United States AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe AI In Vitro Diagnostic Market Share by Country (2018-2029)

    Figure 27. Germany AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific AI In Vitro Diagnostic Market Share by Region (2018-2029)

    Figure 35. China AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America AI In Vitro Diagnostic Market Share by Country (2018-2029)

    Figure 43. Mexico AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa AI In Vitro Diagnostic Market Share by Country (2018-2029)

    Figure 47. Turkey AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia AI In Vitro Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Renalytix Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 50. Seegene Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 51. Sysmex Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 52. PathAI Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 53. Prognos Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 54. Qiagen Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 55. CloudMedX Health Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 56. Deepcell Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 57. Digital Diagnostics Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 58. EKF Diagnostics Holdings Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 59. Freenome Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 60. GE Healthcare Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 61. Glooko Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 62. Adaptive Biotechnologies Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 63. Aidoc Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 64. Anumana Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 65. ARUP Laboratories Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 66. K Health Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 67. Lunit Revenue Growth Rate in AI In Vitro Diagnostic Business (2018-2023)

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed